… SARS-CoV-2 with a focus on vaccine development and its challenges. Vaccines are being
rapidly developed … the development of vaccines against rapidly emerging viruses. Importantly, …

… vaccine candidates were developed against the SARS-CoV-1 and … focus on the current
development of SARS-CoV-2 vaccines … This amazingly rapid development cycle is due to several …

… developments … development of a small-molecule drug are historically >6–7 years, and in
the best case less than 2 years. Vaccines can be developed much faster, but rapid development …

… Here we describe the rapid development of a HT diagnostic platform for the detection of
SARS-CoV-2, using a synthetic VLP developed in-house under biosafety level 1 conditions. We …

… no SARS-CoV-2–specific treatments or vaccines available. Therefore, rapid development
of effective vaccines against SARS-CoV-2 are urgently needed. Here, we developed a pilot-…

… We have developed a rapid and simple point‐of‐care lateral … ) and IgG antibodies
simultaneously against SARS‐CoV‐2 virus in … It can be used for the rapid screening of …

… S protein was the main target for the development of the subunit vaccine against SARS-CoV,
MERS-CoV, and SARS-CoV-2 for its critical role in the entry of the virus into host cells. …

… concerned by the lack of focus and/or concerted efforts toward the rapid development of
therapeutics specifically tailored for CoV-2. Coronaviruses are susceptible to RNA interference, …

… coronavirus 2 (SARS-CoV-2) has spread worldwide. The RNA genome of SARS-CoV-2,
which is highly infectious and prone to rapid … Therefore, the rapid development of SARS-CoV-2 …

… to start the effort of developing an Omicron mRNA vaccine … study to accelerate research and
development process, and a … antibodies not only against the WT SARS-CoV-2 but also the …